<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2018-01-31" version="202">
<accession>P50750</accession>
<accession>Q5JU24</accession>
<accession>Q5JU25</accession>
<accession>Q5U006</accession>
<accession>Q96TF1</accession>
<name>CDK9_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cyclin-dependent kinase 9</fullName>
<ecNumber>2.7.11.22</ecNumber>
<ecNumber>2.7.11.23</ecNumber>
</recommendedName>
<alternativeName>
<fullName>C-2K</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell division cycle 2-like protein kinase 4</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell division protein kinase 9</fullName>
</alternativeName>
<alternativeName>
<fullName>Serine/threonine-protein kinase PITALRE</fullName>
</alternativeName>
<alternativeName>
<fullName>Tat-associated kinase complex catalytic subunit</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDK9</name>
<name type="synonym">CDC2L4</name>
<name type="synonym">TAK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="3834" last="3838">
<title>PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.</title>
<authorList>
<person name="Grana X."/>
<person name="de Luca A."/>
<person name="Sang N."/>
<person name="Fu Y."/>
<person name="Claudio P.P."/>
<person name="Rosenblatt J."/>
<person name="Morgan D.O."/>
<person name="Giordano A."/>
</authorList>
<dbReference type="PubMed" id="8170997"/>
<dbReference type="DOI" id="10.1073/pnas.91.9.3834"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Biochem. Biophys. Res. Commun." volume="208" first="562" last="568">
<title>Cloning of a full-length cDNA sequence encoding a cdc2-related protein kinase from human endothelial cells.</title>
<authorList>
<person name="Best J.L."/>
<person name="Presky D.H."/>
<person name="Swerlick R.A."/>
<person name="Burns D.K."/>
<person name="Chu W."/>
</authorList>
<dbReference type="PubMed" id="7695608"/>
<dbReference type="DOI" id="10.1006/bbrc.1995.1375"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-231</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Gene" volume="252" first="51" last="59">
<title>Genomic organization and characterization of promoter function of the human CDK9 gene.</title>
<authorList>
<person name="Liu H."/>
<person name="Rice A.P."/>
</authorList>
<dbReference type="PubMed" id="10903437"/>
<dbReference type="DOI" id="10.1016/S0378-1119(00)00215-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ALA-231</scope>
</reference>
<reference key="4">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2002-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Cervix</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Cell" volume="92" first="451" last="462">
<title>A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.</title>
<authorList>
<person name="Wei P."/>
<person name="Garber M.E."/>
<person name="Fang S.-M."/>
<person name="Fischer W.H."/>
<person name="Jones K.A."/>
</authorList>
<dbReference type="PubMed" id="9491887"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80939-3"/>
</citation>
<scope>INTERACTION WITH HIV TAT</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="7395" last="7403">
<title>Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.</title>
<authorList>
<person name="Wada T."/>
<person name="Takagi T."/>
<person name="Yamaguchi Y."/>
<person name="Watanabe D."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="9857195"/>
<dbReference type="DOI" id="10.1093/emboj/17.24.7395"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="755" last="762">
<title>Identification of multiple cyclin subunits of human P-TEFb.</title>
<authorList>
<person name="Peng J.-M."/>
<person name="Zhu Y."/>
<person name="Milton J.T."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="9499409"/>
<dbReference type="DOI" id="10.1101/gad.12.5.755"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CCNT1 AND CCNT2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
<title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
<authorList>
<person name="Parada C.A."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="10393184"/>
<dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; RNA POL II; SUPT5H AND NCL</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="34527" last="34530">
<title>Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.</title>
<authorList>
<person name="Fu T.J."/>
<person name="Peng J."/>
<person name="Lee G."/>
<person name="Price D.H."/>
<person name="Flores O."/>
</authorList>
<dbReference type="PubMed" id="10574912"/>
<dbReference type="DOI" id="10.1074/jbc.274.49.34527"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCNK</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="1067" last="1072">
<title>FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.</title>
<authorList>
<person name="Wada T."/>
<person name="Orphanides G."/>
<person name="Hasegawa J."/>
<person name="Kim D.-K."/>
<person name="Shima D."/>
<person name="Yamaguchi Y."/>
<person name="Fukuda A."/>
<person name="Hisatake K."/>
<person name="Oh S."/>
<person name="Reinberg D."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="10912001"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80272-5"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="2970" last="2983">
<title>Domains in the SPT5 protein that modulate its transcriptional regulatory properties.</title>
<authorList>
<person name="Ivanov D."/>
<person name="Kwak Y.T."/>
<person name="Guo J."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="10757782"/>
<dbReference type="DOI" id="10.1128/MCB.20.9.2970-2983.2000"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="6958" last="6969">
<title>CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.</title>
<authorList>
<person name="Garber M.E."/>
<person name="Mayall T.P."/>
<person name="Suess E.M."/>
<person name="Meisenhelder J."/>
<person name="Thompson N.E."/>
<person name="Jones K.A."/>
</authorList>
<dbReference type="PubMed" id="10958691"/>
<dbReference type="DOI" id="10.1128/MCB.20.18.6958-6969.2000"/>
</citation>
<scope>PHOSPHORYLATION BY PKA</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT SER-347; THR-350; SER-353; THR-354 AND SER-357</scope>
<scope>INTERACTION WITH HIV TAT</scope>
<scope>MUTAGENESIS OF 347-SER--SER-357 AND ASP-167</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12317" last="12323">
<title>Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.</title>
<authorList>
<person name="Kim J.B."/>
<person name="Sharp P.A."/>
</authorList>
<dbReference type="PubMed" id="11145967"/>
<dbReference type="DOI" id="10.1074/jbc.M010908200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-167 AND THR-186</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12951" last="12958">
<title>DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.</title>
<authorList>
<person name="Ping Y.-H."/>
<person name="Rana T.M."/>
</authorList>
<dbReference type="PubMed" id="11112772"/>
<dbReference type="DOI" id="10.1074/jbc.M006130200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Mol. Biol." volume="312" first="675" last="685">
<title>The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9.</title>
<authorList>
<person name="Lavoie S.B."/>
<person name="Albert A.L."/>
<person name="Handa H."/>
<person name="Vincent M."/>
<person name="Bensaude O."/>
</authorList>
<dbReference type="PubMed" id="11575923"/>
<dbReference type="DOI" id="10.1006/jmbi.2001.4991"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="16873" last="16878">
<title>P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.</title>
<authorList>
<person name="Lin X."/>
<person name="Taube R."/>
<person name="Fujinaga K."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="11884399"/>
<dbReference type="DOI" id="10.1074/jbc.M200117200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCNK/CYCLIN K</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Biomed. Sci." volume="9" first="234" last="245">
<title>MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein.</title>
<authorList>
<person name="Estable M.C."/>
<person name="Naghavi M.H."/>
<person name="Kato H."/>
<person name="Xiao H."/>
<person name="Qin J."/>
<person name="Vahlne A."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="12065898"/>
<dbReference type="DOI" id="10.1007/BF02256070"/>
</citation>
<scope>INTERACTION WITH AFF4</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="J. Cell. Physiol." volume="192" first="209" last="215">
<title>CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization.</title>
<authorList>
<person name="Napolitano G."/>
<person name="Licciardo P."/>
<person name="Carbone R."/>
<person name="Majello B."/>
<person name="Lania L."/>
</authorList>
<dbReference type="PubMed" id="12115727"/>
<dbReference type="DOI" id="10.1002/jcp.10130"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="1079" last="1093">
<title>Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.</title>
<authorList>
<person name="Bourgeois C.F."/>
<person name="Kim Y.K."/>
<person name="Churcher M.J."/>
<person name="West M.J."/>
<person name="Karn J."/>
</authorList>
<dbReference type="PubMed" id="11809800"/>
<dbReference type="DOI" id="10.1128/MCB.22.4.1079-1093.2002"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="4137" last="4148">
<title>Activation of MyoD-dependent transcription by cdk9/cyclin T2.</title>
<authorList>
<person name="Simone C."/>
<person name="Stiegler P."/>
<person name="Bagella L."/>
<person name="Pucci B."/>
<person name="Bellan C."/>
<person name="De Falco G."/>
<person name="De Luca A."/>
<person name="Guanti G."/>
<person name="Puri P.L."/>
<person name="Giordano A."/>
</authorList>
<dbReference type="PubMed" id="12037670"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205493"/>
</citation>
<scope>FUNCTION AS MYOD1 KINASE</scope>
<scope>INTERACTION WITH MYOD1 AND CCNT2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="1055" last="1066">
<title>Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties.</title>
<authorList>
<person name="Kwak Y.T."/>
<person name="Guo J."/>
<person name="Prajapati S."/>
<person name="Park K.-J."/>
<person name="Surabhi R.M."/>
<person name="Miller B."/>
<person name="Gehrig P."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="12718890"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00101-1"/>
</citation>
<scope>INTERACTION WITH SUPT5H</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Virol." volume="78" first="13522" last="13533">
<title>Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.</title>
<authorList>
<person name="Zhou M."/>
<person name="Deng L."/>
<person name="Lacoste V."/>
<person name="Park H.U."/>
<person name="Pumfery A."/>
<person name="Kashanchi F."/>
<person name="Brady J.N."/>
<person name="Kumar A."/>
</authorList>
<dbReference type="PubMed" id="15564463"/>
<dbReference type="DOI" id="10.1128/JVI.78.24.13522-13533.2004"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="787" last="795">
<title>Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.</title>
<authorList>
<person name="Fujinaga K."/>
<person name="Irwin D."/>
<person name="Huang Y."/>
<person name="Taube R."/>
<person name="Kurosu T."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="14701750"/>
<dbReference type="DOI" id="10.1128/MCB.24.2.787-795.2004"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28819" last="28826">
<title>Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.</title>
<authorList>
<person name="Li Q."/>
<person name="Price J.P."/>
<person name="Byers S.A."/>
<person name="Cheng D."/>
<person name="Peng J."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="15965233"/>
<dbReference type="DOI" id="10.1074/jbc.M502712200"/>
</citation>
<scope>IDENTIFICATION IN INACTIVE 7SK SNRNP COMPLEX</scope>
<scope>PHOSPHORYLATION AT THR-186</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="523" last="534">
<title>The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.</title>
<authorList>
<person name="Jang M.K."/>
<person name="Mochizuki K."/>
<person name="Zhou M."/>
<person name="Jeong H.S."/>
<person name="Brady J.N."/>
<person name="Ozato K."/>
</authorList>
<dbReference type="PubMed" id="16109376"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.06.027"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRD4</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="535" last="545">
<title>Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.</title>
<authorList>
<person name="Yang Z."/>
<person name="Yik J.H."/>
<person name="Chen R."/>
<person name="He N."/>
<person name="Jang M.K."/>
<person name="Ozato K."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="16109377"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.06.029"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRD4</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="37091" last="37102">
<title>The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression.</title>
<authorList>
<person name="Hou T."/>
<person name="Ray S."/>
<person name="Brasier A.R."/>
</authorList>
<dbReference type="PubMed" id="17956865"/>
<dbReference type="DOI" id="10.1074/jbc.M706458200"/>
</citation>
<scope>FUNCTION IN CYTOKINE SIGNALING</scope>
<scope>INTERACTION WITH STAT3</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="262" last="274">
<title>Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.</title>
<authorList>
<person name="Jeronimo C."/>
<person name="Forget D."/>
<person name="Bouchard A."/>
<person name="Li Q."/>
<person name="Chua G."/>
<person name="Poitras C."/>
<person name="Therien C."/>
<person name="Bergeron D."/>
<person name="Bourassa S."/>
<person name="Greenblatt J."/>
<person name="Chabot B."/>
<person name="Poirier G.G."/>
<person name="Hughes T.R."/>
<person name="Blanchette M."/>
<person name="Price D.H."/>
<person name="Coulombe B."/>
</authorList>
<dbReference type="PubMed" id="17643375"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.06.027"/>
</citation>
<scope>IDENTIFICATION IN THE 7SK SNRNP COMPLEX</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="4641" last="4651">
<title>Regulation of P-TEFb elongation complex activity by CDK9 acetylation.</title>
<authorList>
<person name="Fu J."/>
<person name="Yoon H.-G."/>
<person name="Qin J."/>
<person name="Wong J."/>
</authorList>
<dbReference type="PubMed" id="17452463"/>
<dbReference type="DOI" id="10.1128/MCB.00857-06"/>
</citation>
<scope>ACETYLATION AT LYS-44 BY P300/CBP</scope>
<scope>IDENTIFICATION IN COMPLEX WITH NCOR1; HEXIM1 AND HDAC3</scope>
<scope>MUTAGENESIS OF LYS-44</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="1356" last="1368">
<title>PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.</title>
<authorList>
<person name="Chen R."/>
<person name="Liu M."/>
<person name="Li H."/>
<person name="Xue Y."/>
<person name="Ramey W.N."/>
<person name="He N."/>
<person name="Ai N."/>
<person name="Luo H."/>
<person name="Zhu Y."/>
<person name="Zhou N."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="18483222"/>
<dbReference type="DOI" id="10.1101/gad.1636008"/>
</citation>
<scope>PHOSPHORYLATION AT THR-186</scope>
<scope>DEPHOSPHORYLATION BY PPP1CA</scope>
<scope>P-TEFB/7SK SNRNP COMPLEX</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH BRD4</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="33578" last="33584">
<title>Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop.</title>
<authorList>
<person name="Wang Y."/>
<person name="Dow E.C."/>
<person name="Liang Y.Y."/>
<person name="Ramakrishnan R."/>
<person name="Liu H."/>
<person name="Sung T.L."/>
<person name="Lin X."/>
<person name="Rice A.P."/>
</authorList>
<dbReference type="PubMed" id="18829461"/>
<dbReference type="DOI" id="10.1074/jbc.M807495200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-186</scope>
<scope>DEPHOSPHORYLATION BY PPM1A AND PPM1B</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="588" last="599">
<title>A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis.</title>
<authorList>
<person name="He N."/>
<person name="Jahchan N.S."/>
<person name="Hong E."/>
<person name="Li Q."/>
<person name="Bayfield M.A."/>
<person name="Maraia R.J."/>
<person name="Luo K."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="18249148"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.01.003"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH LARP7 IN 7SK SNRNP COMPLEX</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="2201" last="2212">
<title>Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.</title>
<authorList>
<person name="Sabo A."/>
<person name="Lusic M."/>
<person name="Cereseto A."/>
<person name="Giacca M."/>
</authorList>
<dbReference type="PubMed" id="18250157"/>
<dbReference type="DOI" id="10.1128/MCB.01557-07"/>
</citation>
<scope>ACETYLATION AT LYS-44 AND LYS-48 BY PCAF/KAT2B AND GCN5/KAT2A</scope>
<scope>ENZYME REGULATION BY ACETYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="3623" last="3638">
<title>RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes.</title>
<authorList>
<person name="Nowak D.E."/>
<person name="Tian B."/>
<person name="Jamaluddin M."/>
<person name="Boldogh I."/>
<person name="Vergara L.A."/>
<person name="Choudhary S."/>
<person name="Brasier A.R."/>
</authorList>
<dbReference type="PubMed" id="18362169"/>
<dbReference type="DOI" id="10.1128/MCB.01152-07"/>
</citation>
<scope>FUNCTION IN CYTOKINE SIGNALING</scope>
<scope>INTERACTION WITH RELA/P65</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Cell Cycle" volume="8" first="3636" last="3642">
<title>Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing.</title>
<authorList>
<person name="Pirngruber J."/>
<person name="Shchebet A."/>
<person name="Johnsen S.A."/>
</authorList>
<dbReference type="PubMed" id="19844166"/>
<dbReference type="DOI" id="10.4161/cc.8.22.9890"/>
</citation>
<scope>FUNCTION IN HISTONE REGULATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="EMBO Rep." volume="10" first="894" last="900">
<title>CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing.</title>
<authorList>
<person name="Pirngruber J."/>
<person name="Shchebet A."/>
<person name="Schreiber L."/>
<person name="Shema E."/>
<person name="Minsky N."/>
<person name="Chapman R.D."/>
<person name="Eick D."/>
<person name="Aylon Y."/>
<person name="Oren M."/>
<person name="Johnsen S.A."/>
</authorList>
<dbReference type="PubMed" id="19575011"/>
<dbReference type="DOI" id="10.1038/embor.2009.108"/>
</citation>
<scope>FUNCTION IN HISTONE H2B UBIQUITINATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347 AND THR-350</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="397" first="245" last="250">
<title>55K isoform of CDK9 associates with Ku70 and is involved in DNA repair.</title>
<authorList>
<person name="Liu H."/>
<person name="Herrmann C.H."/>
<person name="Chiang K."/>
<person name="Sung T.L."/>
<person name="Moon S.H."/>
<person name="Donehower L.A."/>
<person name="Rice A.P."/>
</authorList>
<dbReference type="PubMed" id="20493174"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.05.092"/>
</citation>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>INTERACTION WITH KU70/XRCC6</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="EMBO Rep." volume="11" first="876" last="882">
<title>Cyclin-dependent kinase 9-cyclin K functions in the replication stress response.</title>
<authorList>
<person name="Yu D.S."/>
<person name="Zhao R."/>
<person name="Hsu E.L."/>
<person name="Cayer J."/>
<person name="Ye F."/>
<person name="Guo Y."/>
<person name="Shyr Y."/>
<person name="Cortez D."/>
</authorList>
<dbReference type="PubMed" id="20930849"/>
<dbReference type="DOI" id="10.1038/embor.2010.153"/>
</citation>
<scope>FUNCTION IN CDK9/CYCLIN K COMPLEX DURING REPLICATION STRESS</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="9556" last="9568">
<title>Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.</title>
<authorList>
<person name="Sunagawa Y."/>
<person name="Morimoto T."/>
<person name="Takaya T."/>
<person name="Kaichi S."/>
<person name="Wada H."/>
<person name="Kawamura T."/>
<person name="Fujita M."/>
<person name="Shimatsu A."/>
<person name="Kita T."/>
<person name="Hasegawa K."/>
</authorList>
<dbReference type="PubMed" id="20081228"/>
<dbReference type="DOI" id="10.1074/jbc.M109.070458"/>
</citation>
<scope>FUNCTION IN CARDIAC HYPERTROPHY</scope>
<scope>IDENTIFICATION IN COMPLEX WITH CCNT1/CYCLIN-T1; EP300 AND GATA4</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Mol. Cell" volume="38" first="428" last="438">
<title>HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.</title>
<authorList>
<person name="He N."/>
<person name="Liu M."/>
<person name="Hsu J."/>
<person name="Xue Y."/>
<person name="Chou S."/>
<person name="Burlingame A."/>
<person name="Krogan N.J."/>
<person name="Alber T."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="20471948"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.04.013"/>
</citation>
<scope>IDENTIFICATION IN THE SEC COMPLEX</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="429" last="437">
<title>AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.</title>
<authorList>
<person name="Lin C."/>
<person name="Smith E.R."/>
<person name="Takahashi H."/>
<person name="Lai K.C."/>
<person name="Martin-Brown S."/>
<person name="Florens L."/>
<person name="Washburn M.P."/>
<person name="Conaway J.W."/>
<person name="Conaway R.C."/>
<person name="Shilatifard A."/>
</authorList>
<dbReference type="PubMed" id="20159561"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.01.026"/>
</citation>
<scope>IDENTIFICATION IN THE SEC COMPLEX</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="Mol. Endocrinol." volume="24" first="2267" last="2280">
<title>CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.</title>
<authorList>
<person name="Gordon V."/>
<person name="Bhadel S."/>
<person name="Wunderlich W."/>
<person name="Zhang J."/>
<person name="Ficarro S.B."/>
<person name="Mollah S.A."/>
<person name="Shabanowitz J."/>
<person name="Hunt D.F."/>
<person name="Xenarios I."/>
<person name="Hahn W.C."/>
<person name="Conaway M."/>
<person name="Carey M.F."/>
<person name="Gioeli D."/>
</authorList>
<dbReference type="PubMed" id="20980437"/>
<dbReference type="DOI" id="10.1210/me.2010-0238"/>
</citation>
<scope>FUNCTION IN AR KINASE</scope>
<scope>INTERACTION WITH AR</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Mol. Cell" volume="44" first="954" last="965">
<title>The little elongation complex regulates small nuclear RNA transcription.</title>
<authorList>
<person name="Smith E.R."/>
<person name="Lin C."/>
<person name="Garrett A.S."/>
<person name="Thornton J."/>
<person name="Mohaghegh N."/>
<person name="Hu D."/>
<person name="Jackson J."/>
<person name="Saraf A."/>
<person name="Swanson S.K."/>
<person name="Seidel C."/>
<person name="Florens L."/>
<person name="Washburn M.P."/>
<person name="Eissenberg J.C."/>
<person name="Shilatifard A."/>
</authorList>
<dbReference type="PubMed" id="22195968"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.12.008"/>
</citation>
<scope>IDENTIFICATION IN THE SEC COMPLEX</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-186</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2012" name="Int. J. Cancer" volume="130" first="1216" last="1226">
<title>CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol.</title>
<authorList>
<person name="Liu X."/>
<person name="Shi S."/>
<person name="Lam F."/>
<person name="Pepper C."/>
<person name="Fischer P.M."/>
<person name="Wang S."/>
</authorList>
<dbReference type="PubMed" id="21484792"/>
<dbReference type="DOI" id="10.1002/ijc.26127"/>
</citation>
<scope>ENZYME REGULATION BY CDKI-71</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5012" last="5022">
<title>Transcription factor IIS cooperates with the E3 ligase UBR5 to ubiquitinate the CDK9 subunit of the positive transcription elongation factor B.</title>
<authorList>
<person name="Cojocaru M."/>
<person name="Bouchard A."/>
<person name="Cloutier P."/>
<person name="Cooper J.J."/>
<person name="Varzavand K."/>
<person name="Price D.H."/>
<person name="Coulombe B."/>
</authorList>
<dbReference type="PubMed" id="21127351"/>
<dbReference type="DOI" id="10.1074/jbc.M110.176628"/>
</citation>
<scope>FUNCTION AS RPB1/POLR2A CTD KINASE</scope>
<scope>POLYUBIQUITINATION BY UBR5</scope>
<scope>INTERACTION WITH UBR5 AND TFIIS/TCEA1</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2012" name="J. Cell. Physiol." volume="227" first="609" last="617">
<title>Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.</title>
<authorList>
<person name="Ramakrishnan R."/>
<person name="Rice A.P."/>
</authorList>
<dbReference type="PubMed" id="21448926"/>
<dbReference type="DOI" id="10.1002/jcp.22760"/>
</citation>
<scope>PHOSPHORYLATION AT THR-186</scope>
<scope>ENZYME REGULATION</scope>
<scope>DEGRADATION BY THE PROTEASOME</scope>
<scope>MUTAGENESIS OF THR-186</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E18985" last="E18985">
<title>Protein phosphatase-1 activates CDK9 by dephosphorylating Ser175.</title>
<authorList>
<person name="Ammosova T."/>
<person name="Obukhov Y."/>
<person name="Kotelkin A."/>
<person name="Breuer D."/>
<person name="Beullens M."/>
<person name="Gordeuk V.R."/>
<person name="Bollen M."/>
<person name="Nekhai S."/>
</authorList>
<dbReference type="PubMed" id="21533037"/>
<dbReference type="DOI" id="10.1371/journal.pone.0018985"/>
</citation>
<scope>PHOSPHORYLATION AT SER-175</scope>
<scope>DEPHOSPHORYLATION AT SER-175 BY PP1</scope>
<scope>MUTAGENESIS OF SER-175</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2006" name="Mol. Cell" volume="23" first="297" last="305">
<title>Controlling the elongation phase of transcription with P-TEFb.</title>
<authorList>
<person name="Peterlin B.M."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="16885020"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.06.014"/>
</citation>
<scope>REVIEW ON NELF AND DSIF KINASE ACTIVITY</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="2661" last="2666">
<title>Expanding role of cyclin dependent kinases in cytokine inducible gene expression.</title>
<authorList>
<person name="Brasier A.R."/>
</authorList>
<dbReference type="PubMed" id="18728388"/>
<dbReference type="DOI" id="10.4161/cc.7.17.6594"/>
</citation>
<scope>REVIEW ON CYTOKINE SIGNALING</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="3664" last="3668">
<title>Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases.</title>
<authorList>
<person name="Romano G."/>
<person name="Giordano A."/>
</authorList>
<dbReference type="PubMed" id="19029809"/>
<dbReference type="DOI" id="10.4161/cc.7.23.7122"/>
</citation>
<scope>REVIEW ON TRANSCRIPTION REGULATION</scope>
<scope>INHIBITORS</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2008" name="Trends Pharmacol. Sci." volume="29" first="302" last="313">
<title>Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology.</title>
<authorList>
<person name="Wang S."/>
<person name="Fischer P.M."/>
</authorList>
<dbReference type="PubMed" id="18423896"/>
<dbReference type="DOI" id="10.1016/j.tips.2008.03.003"/>
</citation>
<scope>REVIEW ON TRANSCRIPTION REGULATION</scope>
<scope>INHIBITORS</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2009" name="Nat. Rev. Cancer" volume="9" first="153" last="166">
<title>Cell cycle, CDKs and cancer: a changing paradigm.</title>
<authorList>
<person name="Malumbres M."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="19238148"/>
<dbReference type="DOI" id="10.1038/nrc2602"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="Med. Res. Rev." volume="30" first="646" last="666">
<title>Pharmacological targeting of CDK9 in cardiac hypertrophy.</title>
<authorList>
<person name="Krystof V."/>
<person name="Chamrad I."/>
<person name="Jorda R."/>
<person name="Kohoutek J."/>
</authorList>
<dbReference type="PubMed" id="19757441"/>
<dbReference type="DOI" id="10.1002/med.20172"/>
</citation>
<scope>REVIEW ON CARDIAC HYPERTROPHY</scope>
<scope>INHIBITORS</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2011" name="Cell Cycle" volume="10" first="28" last="32">
<title>A role for cdk9-cyclin k in maintaining genome integrity.</title>
<authorList>
<person name="Yu D.S."/>
<person name="Cortez D."/>
</authorList>
<dbReference type="PubMed" id="21200140"/>
<dbReference type="DOI" id="10.4161/cc.10.1.14364"/>
</citation>
<scope>REVIEW ON GENOME INTEGRITY MAINTENANCE</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E45749" last="E45749">
<title>Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb.</title>
<authorList>
<person name="Guo L."/>
<person name="Wu W.J."/>
<person name="Liu L.D."/>
<person name="Wang L.C."/>
<person name="Zhang Y."/>
<person name="Wu L.Q."/>
<person name="Guan Y."/>
<person name="Li Q.H."/>
</authorList>
<dbReference type="PubMed" id="23029222"/>
<dbReference type="DOI" id="10.1371/journal.pone.0045749"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN ICP22</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-54 (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="64">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="26294" last="26294">
<title>Heat shock factor 1 mediates latent HIV reactivation.</title>
<authorList>
<person name="Pan X.Y."/>
<person name="Zhao W."/>
<person name="Zeng X.Y."/>
<person name="Lin J."/>
<person name="Li M.M."/>
<person name="Shen X.T."/>
<person name="Liu S.W."/>
</authorList>
<dbReference type="PubMed" id="27189267"/>
<dbReference type="DOI" id="10.1038/srep26294"/>
</citation>
<scope>INTERACTION WITH HSF1</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="Nature" volume="465" first="747" last="751">
<title>Crystal structure of HIV-1 Tat complexed with human P-TEFb.</title>
<authorList>
<person name="Tahirov T.H."/>
<person name="Babayeva N.D."/>
<person name="Varzavand K."/>
<person name="Cooper J.J."/>
<person name="Sedore S.C."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="20535204"/>
<dbReference type="DOI" id="10.1038/nature09131"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-345 IN COMPLEX WITH HIV-1 TAT AND CCNT1</scope>
<scope>PHOSPHORYLATION AT THR-186</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="1907" last="1918">
<title>The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.</title>
<authorList>
<person name="Baumli S."/>
<person name="Lolli G."/>
<person name="Lowe E.D."/>
<person name="Troiani S."/>
<person name="Rusconi L."/>
<person name="Bullock A.N."/>
<person name="Debreczeni J.E."/>
<person name="Knapp S."/>
<person name="Johnson L.N."/>
</authorList>
<dbReference type="PubMed" id="18566585"/>
<dbReference type="DOI" id="10.1038/emboj.2008.121"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF 2-330 IN COMPLEX WITH INHIBITOR FLAVOPIRIDOL; ATP AND CCNT1</scope>
<scope>PHOSPHORYLATION AT THR-186 SER-347; THR-362 AND THR-363</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF THR-186</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2010" name="Chem. Biol." volume="17" first="931" last="936">
<title>Halogen bonds form the basis for selective P-TEFb inhibition by DRB.</title>
<authorList>
<person name="Baumli S."/>
<person name="Endicott J.A."/>
<person name="Johnson L.N."/>
</authorList>
<dbReference type="PubMed" id="20851342"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2010.07.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 2-330 IN COMPLEX WITH INHIBITOR DRB</scope>
<scope>PHOSPHORYLATION AT THR-186</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2010" name="Genes Cancer" volume="1" first="369" last="380">
<title>CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells.</title>
<authorList>
<person name="Bettayeb K."/>
<person name="Baunbaek D."/>
<person name="Delehouze C."/>
<person name="Loaec N."/>
<person name="Hole A.J."/>
<person name="Baumli S."/>
<person name="Endicott J.A."/>
<person name="Douc-Rasy S."/>
<person name="Benard J."/>
<person name="Oumata N."/>
<person name="Galons H."/>
<person name="Meijer L."/>
</authorList>
<dbReference type="PubMed" id="21779453"/>
<dbReference type="DOI" id="10.1177/1947601910369817"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 2-330 IN COMPLEX WITH CCNT1; INHIBITORS ROSCOVITINE AND CR8</scope>
<scope>PHOSPHORYLATION AT THR-186</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] LEU-59</scope>
</reference>
<comment type="function">
<text evidence="14 15 16 18 20 21 22 23 24 25 28 29 31 32 36 39 44 45 46 49 52 53 54 65">Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="38 40 43 55 56 58">Inhibited by CDKI-71, CR8, GPC-286199, AG-024322, flavopiridol (alvocidib), RBG-286147, anilinopyrimidine 32, arylazopyrazole 31b, indirubin 3'-monoxime, meriolin 3,P276-00, olomoucine II, pyrazolotriazine, meriolin, variolin, thiazolyl-pyrimidine, thiazolyl-pyrimidine, indirubin-30-monoxime, ZK 304709, AG-012986, AT7519, R547, RGB-286638, imidazole pyrimidine, EXEL-3700, EXEL-8647, 5,6-dichloro-1-b-ribofur-anosyl-benzimidazole (DRB), P276-00, roscovitine (seliciclib, CYC202) and SNS-032 (BMS-387032). Activation by Thr-186 phosphorylation is calcium Ca(2+) signaling pathway-dependent; actively inactivated by dephosphorylation mediated by PPP1CA, PPM1A and PPM1B. Reversibly repressed by acetylation at Lys-44 and Lys-48.</text>
</comment>
<comment type="subunit">
<text evidence="11 14 15 19 24 25 26 27 30 31 32 34 35 36 37 39 40 41 46 47 48 49 50 51 53 54 58 59 60 61 63 64">Component of the super elongation complex (SEC), at least composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb complex and ELL (ELL, ELL2 or ELL3). Associates with CCNT1/cyclin-T1, CCNT2/cyclin-T2 (isoform A and isoform B) or CCNK/cyclin-K to form active P-TEFb. P-TEFb forms a complex with AFF4/AF5Q31 and is part of the super elongation complex (SEC). Component of a complex which is composed of at least 5 members: HTATSF1/Tat-SF1, P-TEFb complex, RNA pol II, SUPT5H, and NCL/nucleolin. Associates with UBR5 and forms a transcription regulatory complex composed of CDK9, RNAP II, UBR5 and TFIIS/TCEA1 that can stimulate target gene transcription (e.g. gamma fibrinogen/FGG) by recruiting their promoters. Component of the 7SK snRNP inactive complex which is composed of at least 8 members: P-TEFb (composed of CDK9 and CCNT1/cyclin-T1), HEXIM1, HEXIM2, LARP7, BCDIN3, SART3 proteins and 7SK and U6 snRNAs. This inactive 7SK snRNP complex can also interact with NCOR1 and HDAC3, probably to regulate CDK9 acetylation. Release of P-TEFb from P-TEFb/7SK snRNP complex requires both PP2B to transduce calcium Ca(2+) signaling in response to stimuli (e.g. UV or hexamethylene bisacetamide (HMBA)), and PPP1CA to dephosphorylate Thr-186. This released P-TEFb remains inactive in the pre-initiation complex with BRD4 until new Thr-186 phosphorylation occurs after the synthesis of a short RNA. Interacts with BRD4, probably to target chromatin binding. Interacts with the acidic/proline-rich region of HIV-1 and HIV-2 Tat via T-loop region, and is thus required for HIV to hijack host transcription machinery during its replication through cooperative binding to viral TAR RNA. Interacts with activated nuclear STAT3 and RELA/p65. Binds to AR and MYOD1. Forms a complex composed of CDK9, CCNT1/cyclin-T1, EP300 and GATA4 that stimulates hypertrophy in cardiomyocytes. The large PER complex involved in the repression of transcriptional termination is composed of at least PER2, CDK9, DDX5, DHX9, NCBP1 and POLR2A. Isoform 3 binds to KU70/XRCC6. Interacts with herpes simplex virus 1 protein ICP22; this interaction inhibits the positive transcription elongation factor b (P-TEFb). Interacts with HSF1 (PubMed:27189267). Interacts with TBX21 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-968983">
<id>Q13535</id>
<label>ATR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-747353">
<id>Q8WXE1</id>
<label>ATRIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-9345088">
<id>O60885-1</id>
<label>BRD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-2479671">
<id>O60563</id>
<label>CCNT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-1369377">
<id>Q9HAW4</id>
<label>CLSPN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-1211456">
<id>Q7L2E3</id>
<label>DHX30</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-306914">
<id>Q13451</id>
<label>FKBP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-2832510">
<id>O94992</id>
<label>HEXIM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-8464037">
<id>Q6NYC1</id>
<label>JMJD6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-2371923">
<id>Q4G0J3</id>
<label>LARP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12029902"/>
<interactant intactId="EBI-12029900">
<id>Q6XYB7-2</id>
<label>LBX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-7216962">
<id>Q9Y5X4</id>
<label>NR2E3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-716663">
<id>P53041</id>
<label>PPP5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383449"/>
<interactant intactId="EBI-6164389">
<id>P04608</id>
<label>tat</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Accumulates on chromatin in response to replication stress. Complexed with CCNT1 in nuclear speckles, but uncomplexed form in the cytoplasm. The translocation from nucleus to cytoplasm is XPO1/CRM1-dependent. Associates with PML body when acetylated.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P50750-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P50750-2</id>
<name>2</name>
<sequence type="described" ref="VSP_016288"/>
<text evidence="7 8 10">Contains a phosphoserine at position 35. Contains a phosphothreonine at position 54.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous.</text>
</comment>
<comment type="induction">
<text>By replication stress, in chromatin. Probably degraded by the proteasome upon Thr-186 dephosphorylation.</text>
</comment>
<comment type="PTM">
<text evidence="19 30 40 41 42 50 51 55 57 58">Autophosphorylation at Thr-186, Ser-347, Thr-350, Ser-353, Thr-354 and Ser-357 triggers kinase activity by promoting cyclin and substrate binding (e.g. HIV TAT) upon conformational changes. Thr-186 phosphorylation requires the calcium Ca(2+) signaling pathway, including CaMK1D and calmodulin. This inhibition is relieved by Thr-29 dephosphorylation. However, phosphorylation at Thr-29 is inhibitory within the HIV transcription initiation complex. Phosphorylation at Ser-175 inhibits kinase activity. Can be phosphorylated on either Thr-362 or Thr-363 but not on both simultaneously (PubMed:18566585).</text>
</comment>
<comment type="PTM">
<text>Dephosphorylation of Thr-186 by PPM1A and PPM1B blocks CDK9 activity and may lead to CDK9 proteasomal degradation. However, PPP1CA-mediated Thr-186 dephosphorylation is required to release P-TEFb from its inactive P-TEFb/7SK snRNP complex. Dephosphorylation of C-terminus Thr and Ser residues by protein phosphatase-1 (PP1) triggers CDK9 activity, contributing to the activation of HIV-1 transcription.</text>
</comment>
<comment type="PTM">
<text evidence="34 38">N6-acetylation of Lys-44 by CBP/p300 promotes kinase activity, whereas acetylation of both Lys-44 and Lys-48 mediated by PCAF/KAT2B and GCN5/KAT2A reduces kinase activity. The acetylated form associates with PML bodies in the nuclear matrix and with the transcriptionally silent HIV-1 genome; deacetylated upon transcription stimulation.</text>
</comment>
<comment type="PTM">
<text evidence="54">Polyubiquitinated and thus activated by UBR5. This ubiquitination is promoted by TFIIS/TCEA1 and favors 'Ser-2' phosphorylation of RPB1/POLR2A CTD.</text>
</comment>
<comment type="disease">
<text>Chronic activation of CDK9 causes cardiac myocyte enlargement leading to cardiac hypertrophy, and confers predisposition to heart failure.</text>
</comment>
<comment type="miscellaneous">
<text evidence="67 68">CDK9 inhibition contributes to the anticancer activity of most CDK inhibitors under clinical investigation (PubMed:18423896 and PubMed:21779453). As a retroviruses target during the hijack of host transcription (e.g. HIV), CDK9 inhibitors might become specific antiretroviral agents (PubMed:18423896). May be a target for cardiac hypertrophy future treatments (PubMed:19757441 and PubMed:18423896). May also be a target in anti-inflammatory therapy in innate immunity and systemic inflammation (PubMed:18728388).</text>
</comment>
<comment type="similarity">
<text evidence="66">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.</text>
</comment>
<comment type="sequence caution" evidence="66">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="CAI39767" version="1"/>
</conflict>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdk9/"/>
</comment>
<dbReference type="EC" id="2.7.11.22"/>
<dbReference type="EC" id="2.7.11.23"/>
<dbReference type="EMBL" id="L25676">
<property type="protein sequence ID" value="AAA35668.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X80230">
<property type="protein sequence ID" value="CAA56516.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF255306">
<property type="protein sequence ID" value="AAF72183.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019903">
<property type="protein sequence ID" value="AAV38706.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF517840">
<property type="protein sequence ID" value="AAM54039.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL162586">
<property type="protein sequence ID" value="CAI39767.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL162586">
<property type="protein sequence ID" value="CAI39768.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001968">
<property type="protein sequence ID" value="AAH01968.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6879.1">
<molecule id="P50750-1"/>
</dbReference>
<dbReference type="PIR" id="A55262">
<property type="entry name" value="A55262"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001252.1">
<molecule id="P50750-1"/>
<property type="nucleotide sequence ID" value="NM_001261.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.150423"/>
<dbReference type="UniGene" id="Hs.706809"/>
<dbReference type="PDB" id="1PF6">
<property type="method" value="Model"/>
<property type="chains" value="A=1-372"/>
</dbReference>
<dbReference type="PDB" id="3BLH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3BLQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3BLR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3LQ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3MI9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-345"/>
</dbReference>
<dbReference type="PDB" id="3MIA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-345"/>
</dbReference>
<dbReference type="PDB" id="3MY1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3TN8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3TNH">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="3TNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.23"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="4BCF">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.01"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="4BCG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.08"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="4BCH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="4BCI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="4BCJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.16"/>
<property type="chains" value="A=2-330"/>
</dbReference>
<dbReference type="PDB" id="4EC8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A=2-372"/>
</dbReference>
<dbReference type="PDB" id="4EC9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A=2-372"/>
</dbReference>
<dbReference type="PDB" id="4IMY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.94"/>
<property type="chains" value="A/C/E=1-330"/>
</dbReference>
<dbReference type="PDB" id="4OGR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/E/I=1-330"/>
</dbReference>
<dbReference type="PDB" id="4OR5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/F=7-332"/>
</dbReference>
<dbReference type="PDB" id="5L1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="5.90"/>
<property type="chains" value="A=1-330"/>
</dbReference>
<dbReference type="PDBsum" id="1PF6"/>
<dbReference type="PDBsum" id="3BLH"/>
<dbReference type="PDBsum" id="3BLQ"/>
<dbReference type="PDBsum" id="3BLR"/>
<dbReference type="PDBsum" id="3LQ5"/>
<dbReference type="PDBsum" id="3MI9"/>
<dbReference type="PDBsum" id="3MIA"/>
<dbReference type="PDBsum" id="3MY1"/>
<dbReference type="PDBsum" id="3TN8"/>
<dbReference type="PDBsum" id="3TNH"/>
<dbReference type="PDBsum" id="3TNI"/>
<dbReference type="PDBsum" id="4BCF"/>
<dbReference type="PDBsum" id="4BCG"/>
<dbReference type="PDBsum" id="4BCH"/>
<dbReference type="PDBsum" id="4BCI"/>
<dbReference type="PDBsum" id="4BCJ"/>
<dbReference type="PDBsum" id="4EC8"/>
<dbReference type="PDBsum" id="4EC9"/>
<dbReference type="PDBsum" id="4IMY"/>
<dbReference type="PDBsum" id="4OGR"/>
<dbReference type="PDBsum" id="4OR5"/>
<dbReference type="PDBsum" id="5L1Z"/>
<dbReference type="ProteinModelPortal" id="P50750"/>
<dbReference type="SMR" id="P50750"/>
<dbReference type="BioGrid" id="107459">
<property type="interactions" value="203"/>
</dbReference>
<dbReference type="CORUM" id="P50750"/>
<dbReference type="DIP" id="DIP-29016N"/>
<dbReference type="ELM" id="P50750"/>
<dbReference type="IntAct" id="P50750">
<property type="interactions" value="77"/>
</dbReference>
<dbReference type="MINT" id="MINT-1532814"/>
<dbReference type="STRING" id="9606.ENSP00000362361"/>
<dbReference type="BindingDB" id="P50750"/>
<dbReference type="ChEMBL" id="CHEMBL3116"/>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Flavopiridol"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1981"/>
<dbReference type="iPTMnet" id="P50750"/>
<dbReference type="PhosphoSitePlus" id="P50750"/>
<dbReference type="BioMuta" id="CDK9"/>
<dbReference type="DMDM" id="68067660"/>
<dbReference type="EPD" id="P50750"/>
<dbReference type="MaxQB" id="P50750"/>
<dbReference type="PaxDb" id="P50750"/>
<dbReference type="PeptideAtlas" id="P50750"/>
<dbReference type="PRIDE" id="P50750"/>
<dbReference type="DNASU" id="1025"/>
<dbReference type="Ensembl" id="ENST00000373264">
<molecule id="P50750-1"/>
<property type="protein sequence ID" value="ENSP00000362361"/>
<property type="gene ID" value="ENSG00000136807"/>
</dbReference>
<dbReference type="GeneID" id="1025"/>
<dbReference type="KEGG" id="hsa:1025"/>
<dbReference type="UCSC" id="uc004bse.3">
<molecule id="P50750-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1025"/>
<dbReference type="DisGeNET" id="1025"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136807.11"/>
<dbReference type="GeneCards" id="CDK9"/>
<dbReference type="HGNC" id="HGNC:1780">
<property type="gene designation" value="CDK9"/>
</dbReference>
<dbReference type="HPA" id="CAB004216"/>
<dbReference type="HPA" id="HPA006738"/>
<dbReference type="MIM" id="603251">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P50750"/>
<dbReference type="OpenTargets" id="ENSG00000136807"/>
<dbReference type="PharmGKB" id="PA26316"/>
<dbReference type="eggNOG" id="KOG0600">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPIR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00890000139396"/>
<dbReference type="HOGENOM" id="HOG000233024"/>
<dbReference type="HOVERGEN" id="HBG014652"/>
<dbReference type="InParanoid" id="P50750"/>
<dbReference type="KO" id="K02211"/>
<dbReference type="OMA" id="KDPTGCD"/>
<dbReference type="OrthoDB" id="EOG091G08Z8"/>
<dbReference type="PhylomeDB" id="P50750"/>
<dbReference type="TreeFam" id="TF101039"/>
<dbReference type="BRENDA" id="2.7.11.22">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="2.7.11.23">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112382">
<property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167152">
<property type="pathway name" value="Formation of HIV elongation complex in the absence of HIV Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167200">
<property type="pathway name" value="Formation of HIV-1 elongation complex containing HIV-1 Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167238">
<property type="pathway name" value="Pausing and recovery of Tat-mediated HIV elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167243">
<property type="pathway name" value="Tat-mediated HIV elongation arrest and recovery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167246">
<property type="pathway name" value="Tat-mediated elongation of the HIV-1 transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167287">
<property type="pathway name" value="HIV elongation arrest and recovery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167290">
<property type="pathway name" value="Pausing and recovery of HIV elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176034">
<property type="pathway name" value="Interactions of Tat with host cellular proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173796">
<property type="pathway name" value="SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807505">
<property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75955">
<property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
</dbReference>
<dbReference type="SignaLink" id="P50750"/>
<dbReference type="SIGNOR" id="P50750"/>
<dbReference type="ChiTaRS" id="CDK9">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P50750"/>
<dbReference type="GeneWiki" id="CDK9"/>
<dbReference type="GeneWiki" id="Cyclin-dependent_kinase_9"/>
<dbReference type="GenomeRNAi" id="1025"/>
<dbReference type="PRO" id="PR:P50750"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136807"/>
<dbReference type="CleanEx" id="HS_CDK9"/>
<dbReference type="ExpressionAtlas" id="P50750">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P50750">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008024">
<property type="term" value="C:cyclin/CDK positive transcription elongation factor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036464">
<property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008023">
<property type="term" value="C:transcription elongation factor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097322">
<property type="term" value="F:7SK snRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030332">
<property type="term" value="F:cyclin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004693">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008353">
<property type="term" value="F:RNA polymerase II carboxy-terminal domain kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001223">
<property type="term" value="F:transcription coactivator binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071157">
<property type="term" value="P:negative regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900364">
<property type="term" value="P:negative regulation of mRNA polyadenylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070816">
<property type="term" value="P:phosphorylation of RNA polymerase II C-terminal domain"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010613">
<property type="term" value="P:positive regulation of cardiac muscle hypertrophy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001168">
<property type="term" value="P:positive regulation of histone H2B ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033129">
<property type="term" value="P:positive regulation of histone phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903839">
<property type="term" value="P:positive regulation of mRNA 3'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050434">
<property type="term" value="P:positive regulation of viral transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006282">
<property type="term" value="P:regulation of DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031056">
<property type="term" value="P:regulation of histone modification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051147">
<property type="term" value="P:regulation of muscle cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031297">
<property type="term" value="P:replication fork processing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042795">
<property type="term" value="P:snRNA transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006368">
<property type="term" value="P:transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Cyclin-dependent kinase 9" id="PRO_0000085800">
<location>
<begin position="1"/>
<end position="372"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="19"/>
<end position="315"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="25"/>
<end position="33"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12 41">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="region of interest" description="T-loop">
<location>
<begin position="166"/>
<end position="191"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="12 13">
<location>
<position position="149"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="12 41">
<location>
<position position="48"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="12 41">
<location>
<position position="167"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by P300/CBP, PCAF/KAT2B and GCN5/KAT2A" evidence="34 38">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF/KAT2B and GCN5/KAT2A" evidence="38">
<location>
<position position="48"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="57">
<location>
<position position="175"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CaMK1D" evidence="9 30 40 41 42 50 51 55 58">
<location>
<position position="186"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK9 and PKA" evidence="7 8 10 19 41">
<location>
<position position="347"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="8 19">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK9" evidence="19">
<location>
<position position="353"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="19">
<location>
<position position="354"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK9" evidence="19">
<location>
<position position="357"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="41">
<location>
<position position="362"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="41">
<location>
<position position="363"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_016288" evidence="66">
<original>M</original>
<variation>MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSGGGGGGASAAPAPPGLSGTTSPRGPGGGRRAEEAGSAPRGRKWPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAAM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55640715." id="VAR_041982" evidence="33">
<original>F</original>
<variation>L</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_013456" evidence="17 62">
<original>G</original>
<variation>A</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired kinase and transcriptional elongation activities, but normal cyclin T1 and HEXIM1 binding." evidence="34">
<original>K</original>
<variation>R</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates kinase activity." evidence="19 21">
<original>D</original>
<variation>N</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive kinase activity." evidence="57">
<original>S</original>
<variation>A</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics phosphorylation, constitutive loss of kinase activity." evidence="57">
<original>S</original>
<variation>D</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates autophosphorylation; no effect on kinase activity, but impaired CTD phosphorylation." evidence="21 41 55">
<original>T</original>
<variation>A</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics autophosphorylation; constitutive kinase activity, independently of calcium signaling." evidence="21 41 55">
<original>T</original>
<variation>D</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation and impaired interaction with HIV TAT." evidence="19">
<original>SQITQQSTNQS</original>
<variation>AQIAQQAANQA</variation>
<location>
<begin position="347"/>
<end position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics autophosphorylation and promotes interaction with HIV TAT." evidence="19">
<original>SQITQQSTNQS</original>
<variation>EQIEQQEENQE</variation>
<location>
<begin position="347"/>
<end position="357"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAV38706." ref="4" evidence="66">
<original>L</original>
<variation>P</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="13"/>
<end position="15"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="16"/>
<end position="18"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="19"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="32"/>
<end position="38"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="39"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="44"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="56"/>
<end position="59"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="61"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="81"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="98"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="110"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="123"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="178"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="192"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="197"/>
<end position="200"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="209"/>
<end position="224"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="234"/>
<end position="245"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="263"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="275"/>
<end position="283"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="286"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="300"/>
<end position="302"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="306"/>
<end position="310"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="313"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="325"/>
<end position="329"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="335"/>
<end position="339"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BLR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LQ5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MI9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MY1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EC9"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OGR"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q99J95"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10393184"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10574912"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10757782"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10903437"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10912001"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10958691"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11112772"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11145967"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11575923"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11809800"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11884399"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12037670"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12065898"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12718890"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14701750"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15564463"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15965233"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16109376"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16109377"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17452463"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643375"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17956865"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18249148"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18250157"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18362169"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18483222"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18566585"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18829461"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19238148"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19575011"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19844166"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20081228"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20159561"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20471948"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20493174"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20535204"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20851342"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20930849"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20980437"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21127351"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21448926"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21484792"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21533037"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21779453"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22195968"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23029222"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27189267"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7695608"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9491887"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9499409"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9857195"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000305"/>
<evidence key="67" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18423896"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18728388"/>
</source>
</evidence>
<sequence length="372" mass="42778" checksum="69E851CC6F7A0388" modified="2005-06-21" version="3">
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP
ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK
FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS
QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL
ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP
AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNP
ATTNQTEFERVF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>